Profound Medical (PROF) Competitors $7.55 +0.03 (+0.40%) (As of 11/22/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends PROF vs. BFLY, IRMD, KIDS, AXGN, SIBN, TMCI, SMLR, TCMD, ZIMV, and NNOXShould you be buying Profound Medical stock or one of its competitors? The main competitors of Profound Medical include Butterfly Network (BFLY), Iradimed (IRMD), OrthoPediatrics (KIDS), AxoGen (AXGN), SI-BONE (SIBN), Treace Medical Concepts (TMCI), Semler Scientific (SMLR), Tactile Systems Technology (TCMD), ZimVie (ZIMV), and Nano-X Imaging (NNOX). These companies are all part of the "medical equipment" industry. Profound Medical vs. Butterfly Network Iradimed OrthoPediatrics AxoGen SI-BONE Treace Medical Concepts Semler Scientific Tactile Systems Technology ZimVie Nano-X Imaging Profound Medical (NASDAQ:PROF) and Butterfly Network (NYSE:BFLY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their valuation, profitability, institutional ownership, media sentiment, earnings, risk, community ranking, dividends and analyst recommendations. Does the MarketBeat Community believe in PROF or BFLY? Profound Medical received 34 more outperform votes than Butterfly Network when rated by MarketBeat users. Likewise, 72.73% of users gave Profound Medical an outperform vote while only 66.67% of users gave Butterfly Network an outperform vote. CompanyUnderperformOutperformProfound MedicalOutperform Votes4072.73% Underperform Votes1527.27% Butterfly NetworkOutperform Votes666.67% Underperform Votes333.33% Do analysts prefer PROF or BFLY? Profound Medical presently has a consensus target price of $13.75, suggesting a potential upside of 82.12%. Butterfly Network has a consensus target price of $3.00, suggesting a potential downside of 7.41%. Given Profound Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe Profound Medical is more favorable than Butterfly Network.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Profound Medical 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 1 Strong Buy rating(s) 3.25Butterfly Network 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is PROF or BFLY more profitable? Butterfly Network has a net margin of -129.25% compared to Profound Medical's net margin of -349.41%. Butterfly Network's return on equity of -42.68% beat Profound Medical's return on equity.Company Net Margins Return on Equity Return on Assets Profound Medical-349.41% -85.22% -64.87% Butterfly Network -129.25%-42.68%-30.31% Does the media favor PROF or BFLY? In the previous week, Butterfly Network had 1 more articles in the media than Profound Medical. MarketBeat recorded 1 mentions for Butterfly Network and 0 mentions for Profound Medical. Profound Medical's average media sentiment score of 0.00 equaled Butterfly Network'saverage media sentiment score. Company Overall Sentiment Profound Medical Neutral Butterfly Network Neutral Which has higher earnings and valuation, PROF or BFLY? Profound Medical has higher earnings, but lower revenue than Butterfly Network. Butterfly Network is trading at a lower price-to-earnings ratio than Profound Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioProfound Medical$7.20M25.86-$28.57M-$1.34-5.63Butterfly Network$65.90M10.48-$133.70M-$0.46-7.04 Which has more volatility and risk, PROF or BFLY? Profound Medical has a beta of 0.83, meaning that its share price is 17% less volatile than the S&P 500. Comparatively, Butterfly Network has a beta of 2.17, meaning that its share price is 117% more volatile than the S&P 500. Do insiders & institutionals have more ownership in PROF or BFLY? 47.9% of Profound Medical shares are held by institutional investors. Comparatively, 37.9% of Butterfly Network shares are held by institutional investors. 1.5% of Profound Medical shares are held by insiders. Comparatively, 27.3% of Butterfly Network shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. SummaryProfound Medical beats Butterfly Network on 10 of the 18 factors compared between the two stocks. Ad Genesis Gold GroupBuffett Dumps $982 Million in BofA Stock—What Does He Know?Buffett's been eerily quiet about his reasons, but his actions speak volumes. When someone with his track record starts pulling out of the market, it's time to pay attention.Get your FREE, no-obligation Wealth Protection Guide now Get Profound Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for PROF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PROF vs. The Competition Export to ExcelMetricProfound MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$186.18M$4.48B$5.21B$8.83BDividend YieldN/A36.80%5.07%4.09%P/E Ratio-5.6325.20113.2217.54Price / Sales25.8646.571,251.41162.39Price / CashN/A53.5739.9036.29Price / Book5.995.907.066.49Net Income-$28.57M$13.81M$118.87M$225.61M7 Day Performance-5.74%3.10%2.20%3.59%1 Month Performance1.48%2.77%-3.08%3.43%1 Year Performance-26.58%47.15%33.58%29.15% Profound Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PROFProfound Medical1.7124 of 5 stars$7.55+0.4%$13.75+82.1%-26.6%$186.18M$7.20M-5.63150BFLYButterfly Network0.7704 of 5 stars$3.24-1.5%$3.00-7.4%+217.6%$690.31M$65.90M-7.16460IRMDIradimed4.5248 of 5 stars$53.23flat$60.00+12.7%+30.5%$674.58M$71.31M36.46110KIDSOrthoPediatrics4.0323 of 5 stars$26.34-0.5%$40.00+51.9%-17.1%$637.85M$189.67M-21.51200AXGNAxoGen2.7069 of 5 stars$13.34+1.8%$15.00+12.4%+126.1%$587.07M$180.86M-41.69426SIBNSI-BONE4.2817 of 5 stars$12.56+2.2%$23.00+83.1%-29.9%$526.74M$157.04M-13.65350Analyst ForecastInsider TradeTMCITreace Medical Concepts0.9925 of 5 stars$7.83-1.4%$7.40-5.5%-9.3%$487.81M$187.12M-7.91250SMLRSemler Scientific1.1109 of 5 stars$63.65-4.2%N/A+72.3%$462.74M$68.18M31.7492News CoverageGap DownHigh Trading VolumeTCMDTactile Systems Technology3.8784 of 5 stars$17.85+12.0%$23.00+28.9%+32.6%$428.35M$285.05M26.31980High Trading VolumeZIMVZimVie2.7273 of 5 stars$14.17+3.1%$18.33+29.4%+55.0%$391.09M$457.43M-1.082,600NNOXNano-X Imaging2.063 of 5 stars$6.36+3.2%$14.00+120.1%+0.8%$367.48M$9.90M-6.69190News Coverage Related Companies and Tools Related Companies BFLY Competitors IRMD Competitors KIDS Competitors AXGN Competitors SIBN Competitors TMCI Competitors SMLR Competitors TCMD Competitors ZIMV Competitors NNOX Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:PROF) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Profound Medical Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Profound Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PROF Stock Alerts